Schuh A, Foerster P, Priglinger S, Eibl-Lindner K
Augenklinik, LMU, Mathildenstr. 8, 80336, München, Deutschland.
Augenärzte Pasinger Hofgärten, München, Deutschland.
Ophthalmologe. 2018 Mar;115(3):226-230. doi: 10.1007/s00347-017-0514-y.
Approach to loss of visual acuity in a patient with a choroidal osteoma (CO) which had been stable for seven years.
Fluorescence angiography confirmed a choroidal neovascularization (CNV) as the cause of the loss of visual acuity. Treatment with intravitreal (IVT) injection of ranibizumab.
Increase of visual acuity and decrease of edema after IVT injection.
Monitoring is necessary even for primarily benign CO in order to detect secondary complications causing loss of visual acuity, e. g. secondary CNV. Anti-VEGF IVT represents an approved treatment option.
探讨一名脉络膜骨瘤（CO）患者视力丧失的处理方法，该脉络膜骨瘤已稳定七年。
荧光血管造影证实脉络膜新生血管（CNV）是视力丧失的原因。采用玻璃体内注射雷珠单抗进行治疗。
玻璃体内注射后视力提高，水肿减轻。
即使是原发性良性脉络膜骨瘤也需要进行监测，以便检测导致视力丧失的继发性并发症，例如继发性脉络膜新生血管。抗血管内皮生长因子玻璃体内注射是一种已获批准的治疗选择。
